IM Cannabis (IMCC) Competitors $1.82 +0.05 (+2.91%) Closing price 03:04 PM EasternExtended Trading$1.84 +0.03 (+1.38%) As of 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMCC vs. SLGL, CLRB, MEIP, SYBX, ORGS, HCWB, BCTX, AFMD, GOVX, and QNTMShould you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Sol-Gel Technologies (SLGL), Cellectar Biosciences (CLRB), MEI Pharma (MEIP), Synlogic (SYBX), Orgenesis (ORGS), HCW Biologics (HCWB), BriaCell Therapeutics (BCTX), Affimed (AFMD), GeoVax Labs (GOVX), and Quantum Biopharma (QNTM). These companies are all part of the "pharmaceutical products" industry. IM Cannabis vs. Sol-Gel Technologies Cellectar Biosciences MEI Pharma Synlogic Orgenesis HCW Biologics BriaCell Therapeutics Affimed GeoVax Labs Quantum Biopharma Sol-Gel Technologies (NASDAQ:SLGL) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings. Do institutionals and insiders hold more shares of SLGL or IMCC? 26.2% of Sol-Gel Technologies shares are owned by institutional investors. Comparatively, 7.7% of IM Cannabis shares are owned by institutional investors. 66.5% of Sol-Gel Technologies shares are owned by insiders. Comparatively, 5.9% of IM Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts recommend SLGL or IMCC? Sol-Gel Technologies currently has a consensus price target of $5.00, suggesting a potential upside of 845.18%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Sol-Gel Technologies is more favorable than IM Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00IM Cannabis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer SLGL or IMCC? In the previous week, Sol-Gel Technologies and Sol-Gel Technologies both had 2 articles in the media. IM Cannabis' average media sentiment score of 0.47 beat Sol-Gel Technologies' score of 0.43 indicating that IM Cannabis is being referred to more favorably in the news media. Company Overall Sentiment Sol-Gel Technologies Neutral IM Cannabis Neutral Which has stronger earnings & valuation, SLGL or IMCC? IM Cannabis has higher revenue and earnings than Sol-Gel Technologies. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$11.71M1.26-$27.24M-$0.34-1.56IM Cannabis$51.39M0.08-$7.04M-$3.41-0.53 Which has more risk & volatility, SLGL or IMCC? Sol-Gel Technologies has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Is SLGL or IMCC more profitable? IM Cannabis has a net margin of -25.55% compared to Sol-Gel Technologies' net margin of -81.75%. Sol-Gel Technologies' return on equity of -27.17% beat IM Cannabis' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-81.75% -27.17% -22.49% IM Cannabis -25.55%-129.86%-23.63% Does the MarketBeat Community favor SLGL or IMCC? Sol-Gel Technologies received 143 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 63.40% of users gave Sol-Gel Technologies an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote. CompanyUnderperformOutperformSol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% IM CannabisOutperform Votes642.86% Underperform Votes857.14% SummarySol-Gel Technologies beats IM Cannabis on 12 of the 17 factors compared between the two stocks. Remove Ads Get IM Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCC vs. The Competition Export to ExcelMetricIM CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.05M$1.12B$5.64B$8.06BDividend YieldN/AN/A4.57%4.02%P/E Ratio-0.539.6823.1319.03Price / Sales0.086.23383.8993.17Price / CashN/A10.4038.1634.64Price / Book0.401.236.944.33Net Income-$7.04M-$53.09M$3.20B$247.06M7 Day Performance1.97%-2.92%-2.30%-0.52%1 Month Performance-13.94%-15.08%3.10%-3.73%1 Year Performance-27.89%-41.66%11.22%1.74% IM Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCCIM Cannabis1.1771 of 5 stars$1.82+2.9%N/A-35.5%$4.05M$51.39M-0.53340Upcoming EarningsShort Interest ↓SLGLSol-Gel Technologies2.4483 of 5 stars$0.57+2.5%$5.00+777.5%-40.5%$15.87M$11.71M-1.6850Short Interest ↑Gap UpCLRBCellectar Biosciences2.1697 of 5 stars$0.34+6.7%$17.67+5,145.4%-90.6%$15.52MN/A-0.2010Analyst ForecastShort Interest ↑Gap UpMEIPMEI Pharma4.3295 of 5 stars$2.32+0.4%$7.00+201.7%-39.9%$15.46M$65.30M-0.40100Short Interest ↓SYBXSynlogic1.8288 of 5 stars$1.31+4.0%N/A-26.5%$15.32M$8,000.00-0.3180Gap UpORGSOrgenesisN/A$3.15-9.0%N/AN/A$15.12M$662,000.000.00150Gap UpHCWBHCW Biologics1.9297 of 5 stars$0.34-0.3%N/A-82.2%$15.10M$3.50M-0.3440Gap DownBCTXBriaCell Therapeutics1.7569 of 5 stars$4.07+6.0%$32.00+686.2%-89.5%$15.10MN/A-0.318News CoverageGap UpAFMDAffimed4.4547 of 5 stars$0.90+2.2%$13.50+1,401.7%-84.4%$14.47M$877,000.000.00200Short Interest ↓GOVXGeoVax Labs3.075 of 5 stars$1.50-2.6%$14.20+846.7%-25.5%$14.15M$3.09M0.0010Earnings ReportShort Interest ↓News CoverageQNTMQuantum BiopharmaN/A$7.18+46.8%N/AN/A$13.78MN/A-0.47N/ANews CoverageGap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies SLGL Competitors CLRB Competitors MEIP Competitors SYBX Competitors ORGS Competitors HCWB Competitors BCTX Competitors AFMD Competitors GOVX Competitors QNTM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMCC) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
